Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia

Human Pathology

Volumn 36, Issue 6, 2005, Pages 626-633

  Lee, Jeong Won ^a   Sang, Yong Song ^a   Choi, Jung Joo ^a   Lee, Sun Joo ^a   Kim, Byoung Gie ^a   Park, Chang Soo ^a   Lee, Je Ho ^a   Lin, Chen Yong ^b   Dickson, Robert B ^b   Bae, Duk Soo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Carcinoma; Cervical intraepithelial neoplasia; Matriptase; Serine protease; Squamous cell

Indexed keywords

FORMALDEHYDE; MATRIPTASE; PARAFFIN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER SURGERY; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; DISEASE COURSE; EMBEDDING; ENZYME ASSAY; FEMALE; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MEDICAL ASSESSMENT; MICRODISSECTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE ENDOCERVIX;

DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LASERS; MICRODISSECTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE ENDOPEPTIDASES; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 21544452009     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2005.03.003     Document Type: Article

References (34)

1. G.M. Yousef, A.D. Kopolovic, and M.B. Elliott Genomic overview of serine proteases Biochem Biophys Res Commun 305 2003 28 36
2. W.H. Horl Proteinases: potential role in health and disease 1989 Oxford University Press Oxford 573 581
3. C.J. Froelich, X. Zhang, and J. Turbov Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes J Immunol 151 1993 7161 7171
4. G.M. Yousef, and E.P. Diamandis The new human tissue kallikrein gene family: structure, function, and association to disease Endocr Rev 22 2001 184 204
5. G.M. Yousef, and E.P. Diamandis Expanded human tissue kallikrein family-a novel panel of cancer biomarkers Tumour Biol 23 2002 185 192
6. E.P. Diamandis, and G.M. Yousef Human tissue kallikreins: a family of new cancer biomarkers Clin Chem 48 2002 1198 1205
7. C.Y. Lin, J. Anders, and M. Johnson Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity J Biol Chem 274 1999 18231 18236
8. Y.E. Shi, J. Torri, and L. Yieh Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells Cancer Res 53 1993 1409 1415
9. C.Y. Lin, J.K. Wang, and J. Torri Characterization of a novel, membrane-bound, 80-kDa matrix-degrading protease from human breast cancer cells. Monoclonal antibody production, isolation, and localization J Biol Chem 272 1997 9147 9152
10. C.Y. Lin, J. Anders, and M. Johnson Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk J Biol Chem 274 1999 18237 18242
11. M.D. Oberst, B. Singh, and M. Ozdemirli Characterization of matriptase expression in normal human tissues J Histochem Cytochem 51 2003 1017 1025
12. M.G. Kim, C. Chen, and M.S. Lyu Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains Immunogenetics 49 1999 420 428
13. K. List, C.C. Haudenschild, and R. Szabo Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis Oncogene 21 2002 3765 3779
14. S.L. Lee, R.B. Dickson, and C.Y. Lin Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease J Biol Chem 275 2000 36720 36725
15. T. Takeuchi, J.L. Harris, and W. Huang Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates J Biol Chem 275 2000 26333 26342
16. S. Satomi, Y. Yamasaki, and S. Tsuzuki A role for membrane-type serine protease (MT-SP1) in intestinal epithelial turnover Biochem Biophys Res Commun 287 2001 995 1002
17. P.M. Comoglio, and C. Boccaccio Scatter factors and invasive growth Semin Cancer Biol 11 2001 153 165
18. P.A. Andreasen, R. Egelund, and H.H. Petersen The plasminogen activation system in tumor growth, invasion, and metastasis Cell Mol Life Sci 57 2000 25 40
19. M. Oberst, J. Anders, and B. Xie Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo Am J Pathol 158 2001 1301 1311
20. H. Tanimoto, L.J. Underwood, and Y. Wang Ovarian tumor cells express a transmembrane serine protease: a potential candidate for early diagnosis and therapeutic intervention Tumour Biol 22 2001 104 114
21. P.J. DiSaia W.T. Creasman Preinvasive disease of the cervix. Clinical gynecologic oncology 6th ed. 2002 C.V. Mosby St. Louis 1 34
22. R.M. Richart A modified terminology for cervical intraepithelial neoplasia Obstet Gynecol 75 1990 131 133
23. R.M. Richart Cervical intraepithelial neoplasia Pathol Annu 8 1973 301 328
24. A.D. Santin, S. Cane, and S. Bellone The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma Cancer 98 2003 1898 1904
25. M.D. Oberst, M.D. Johnson, and R.B. Dickson Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters Clin Cancer Res 8 2002 1101 1107
26. J. Sun, J. Pons, and C.S. Craik Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies Biochemistry 42 2003 892 900
27. J.Y. Kang, M. Dolled-Filhart, and I.T. Ocal Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer Cancer Res 63 2003 1101 1105
28. T. Shimomura, K. Denda, and A. Kitamura Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor J Biol Chem 272 1997 6370 6376
29. H. Kataoka, T. Suganuma, and T. Shimomura Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues J Histochem Cytochem 47 1999 673 682
30. C. Benaud, R.B. Dickson, and C.Y. Lin Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor Eur J Biochem 268 2001 1439 1447
31. C. Benaud, M. Oberst, and J.P. Hobson Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase J Biol Chem 277 2002 10539 10546
32. C.M. Benaud, M. Oberst, and R.B. Dickson Deregulated activation of matriptase in breast cancer cells Clin Exp Metastasis 19 2002 639 649
33. A. Wells Tumor invasion: role of growth factor-induced cell motility Adv Cancer Res 78 2000 31 101
34. R.J. Hung, W. Hsu Ia, and J.L. Dreiling Assembly of adherens junctions is required for sphingosine 1-phosphate-induced matriptase accumulation and activation at mammary epithelial cell-cell contacts Am J Physiol Cell Physiol 286 2004 C1159 C1169